Episode Details

McGill Universitys groundbreaking international study reveals psychedelic drugs like LSD and psilocybin could transform depression and anxiety treatment. A team of 89 experts from 17 countries, including Milas AI institute, found these substances outperform traditional meds in trials. Psychedelics with different chemical structures hit the brain similarly, potentially reshaping prescription methods and drug design. This research aims to make psychedelic therapy more accessible, offering real options for mental illness treatment.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/aff6ff869f7cb3ba